Bard Receives Clearance to Market HemoSplit Dialysis Catheter.Business Editors/Health/Medical Writers MURRAY HILL, N.J.--(BUSINESS WIRE)--July 8, 2003 C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE NYSE See: New York Stock Exchange :BCR BCR B Cell Receptor BCR Business Communications Review (magazine) BCR Banca Comerciala Romana (Romanian bank) BCR Breakpoint Cluster Region BCR Benefit/Cost Ratio BCR Bay City Rollers ) today announced that its wholly-owned subsidiary, Bard Access Systems, Inc., received Food and Drug Administration clearance to market the HemoSplit(TM) catheter for long-term renal dialysis care. Bard Access Systems previously acquired the exclusive rights to this patented technology invented by Dr. Thierry Pourchez, a noted French surgeon. Long-term dialysis catheters are used to provide indwelling indwelling /in·dwell·ing/ (in´dwel-ing) pertaining to a catheter or other tube left within an organ or body passage for drainage, to maintain patency, or for the administration of drugs or nutrients. vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing to end-stage renal-disease patients requiring dialysis treatments. These patients suffer from reduced kidney function, and require cleansing of their blood by a dialysis machine. The HemoSplit catheter is designed to deliver exceptional flow performance due to its robust materials, large lumens and non-restrictive patented, fixed split-tip design. "The approval of our HemoSplit catheter complements our leadership position in the vascular access market and strengthens our dialysis line within that segment," commented William H. Longfield, chairman and chief executive officer, "further, it demonstrates our proven ability to develop new and innovative products to enhance and improve the quality of life." C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
This press release contains forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Please refer to our March 31, 2003, Form 10-Q for a statement with regard to forward-looking statements, including disclosure of additional factors that could cause actual results to differ materially from those expressed or implied. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion